mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.006 |
mRNA |
RDEA119 |
FIMM |
pan-cancer |
AAC |
0.47 |
0.006 |
mRNA |
BRD-K42260513 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.006 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.083 |
0.008 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.076 |
0.009 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.01 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.01 |
mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.02 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.02 |
mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |